Glucocorticoids activate a synapse weakening pathway culminating in tau phosphorylation in the hippocampus

Pharmacol Res. 2017 Jul:121:42-51. doi: 10.1016/j.phrs.2017.04.015. Epub 2017 Apr 14.

Abstract

Evidence suggests that the stress hormones glucocorticoids (GCs) can cause cognitive deficits and neurodegeneration. Previous studies have found GCs facilitate physiological synapse weakening, termed long-term depression (LTD), though the precise mechanisms underlying this are poorly understood. Here we show that GCs activate glycogen synthase kinase-3 (GSK-3), a kinase crucial to synapse weakening signals. Critically, this ultimately leads to phosphorylation of the microtubule associated protein tau, specifically at the serine 396 residue, and this is a causal factor in the GC-mediated impairment of synaptic function. These findings reveal the link between GCs and synapse weakening signals, and the potential for stress-induced priming of neurodegeneration. This could have important implications for our understanding of how stress can lead to neurodegenerative disease.

Keywords: GSK-3; Glucocorticoids; Long-term potentiation; Tau.

MeSH terms

  • Animals
  • Glucocorticoids / metabolism*
  • Glycogen Synthase Kinase 3 / metabolism
  • Hippocampus / physiology*
  • Long-Term Potentiation*
  • Phosphorylation
  • Rats
  • Signal Transduction
  • Synapses / physiology*
  • tau Proteins / metabolism*

Substances

  • Glucocorticoids
  • tau Proteins
  • Glycogen Synthase Kinase 3